Home > PS Ratio > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
PS (Price/Sales) Ratio

The Current P/S Ratio of STRIDES PHARMA SCIENCE is 1.77.

Share Price ₹905.1Mar 18,2026
Market Cap ₹8,345.0 Cr
Sales-TTM₹4,725.6 CrTTM-Consolidated Results
Price/Sales1.77xCalculated as Market Cap/Sales
Explore Stock Analytics
AD     Remove this Ad
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of STRIDES PHARMA SCIENCE

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of STRIDES PHARMA SCIENCE is calculated as :

Current Market Cap [ ₹8,345.0 Cr] as on Mar 18,2026

(/) Sales [ ₹4,725.6 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 1.77x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for STRIDES PHARMA SCIENCE , the investors are currently willing to pay '1.77 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of STRIDES PHARMA SCIENCE !

The chart below summarizes the trend in P/S Ratio of STRIDES PHARMA SCIENCE over the last five years.

Historical PS (Price/Sales) ratio chart of STRIDES PHARMA SCIENCE


PS Ratio Performance Analysis for STRIDES PHARMA SCIENCE

- STRIDES PHARMA SCIENCE 's latest p/e ratio is 1.77x.

- STRIDES PHARMA SCIENCE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.44x.

- STRIDES PHARMA SCIENCE 's operated at median p/e ratio of 1.35x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, STRIDES PHARMA SCIENCE 's p/e ratio peaked in Mar2021 at 2.28x.

- STRIDES PHARMA SCIENCE 's p/e ratio hit its five-year low in Mar2023 of 0.7x.


How does STRIDES PHARMA SCIENCE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
STRIDES PHARMA SCIENCE 4,725.61.778,345.0
SUN PHARMACEUTICAL INDUSTRIES LTD56,809.17.51426,782.0
DIVIS LABORATORIES LTD10,314.015.82163,125.0
CIPLA LTD28,351.13.61102,443.0
TORRENT PHARMACEUTICALS LTD12,742.011.40145,252.0
DR REDDYS LABORATORIES LTD34,682.23.11108,025.0
MANKIND PHARMA LTD13,914.16.2486,793.0
ZYDUS LIFESCIENCES LTD26,089.33.4790,435.3
LUPIN LTD26,150.54.02105,236.0
AUROBINDO PHARMA LTD33,181.92.2273,703.7
ABBOTT INDIA LTD6,824.18.1955,882.2

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs STRIDES PHARMA SCIENCE 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 1.77x
Max industry PS 15.82x
Median industry PS 4.02x
Average industry PS 6.12x



You may also like the below Video Courses